Intech Biopharm Corporation (TPEX:6461)
Taiwan · Delayed Price · Currency is TWD 15.30
-0.15 (-0.97%)
Jul 30, 2026, 1:30 PM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 2.76 billion as of July 29, 2026. Its market cap has decreased by -11.69% in one year.
Market Cap
2.76B
Enterprise Value
3.83B
Revenue
117.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.30
ChartMarket Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 2.76B, a decrease of -31.19%. That is a compound annual growth rate of -3.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 2.76B | -4.98% |
| Dec 31, 2025 | 2.90B | -20.37% |
| Dec 31, 2024 | 3.64B | -11.36% |
| Dec 29, 2023 | 4.11B | 5.65% |
| Dec 30, 2022 | 3.89B | 67.22% |
| Dec 30, 2021 | 2.33B | 11.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sagittarius Life Science | 3.21B |
| SYN-TECH Chem. & Pharm. | 3.20B |
| Apex Biotechnology | 3.17B |
| Shine-On BioMedical | 3.14B |
| 3D Global Biotech | 3.09B |
| Great Novel Therapeutics Biotech & Medicals | 2.89B |
| BRIM Biotechnology | 2.80B |
| Energenesis Biomedical CO.,LTD. | 2.80B |